SLXNW
Biomotion Sciences WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.06
52W High
$0.07
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biomotion Sciences Warrant
Biomotion Sciences Warrant (ticker: SLXNW) is associated with a biotechnology company focused on pioneering therapeutic solutions that aim to enhance patient outcomes and address significant unmet medical needs. The firm's commitment to rigorous research and development underpins its strategy to innovate within the biopharmaceutical sector, positioning it well for future growth. As Biomotion Sciences progresses through clinical trials and forges strategic partnerships, the potential for substantial returns on investment grows, particularly as its product pipeline expands in a rapidly evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-11.62M |
| Operating Margin | 0.00% |
| Return on Equity | -771.00% |
| Return on Assets | -144.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.83 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 159.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $3.30M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/15/2026